GLNJX
Price
$22.18
Change
+$0.01 (+0.05%)
Updated
Sep 16 closing price
Net Assets
72.87M
SCWCX
Price
$61.23
Change
+$0.13 (+0.21%)
Updated
Sep 16 closing price
Net Assets
81.91B
Interact to see
Advertisement

GLNJX vs SCWCX

Header iconGLNJX vs SCWCX Comparison
Open Charts GLNJX vs SCWCXBanner chart's image
MFS Global New Discovery R1
Price$22.18
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets72.87M
American Funds SMALLCAP World C
Price$61.23
Change+$0.13 (+0.21%)
VolumeN/A
Net Assets81.91B
GLNJX vs SCWCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GLNJX vs. SCWCX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLNJX is a Hold and SCWCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SCWCX has more cash in the bank: 81.9B vs. GLNJX (72.9M). SCWCX pays higher dividends than GLNJX: SCWCX (0.04) vs GLNJX (0.00). GLNJX was incepted earlier than SCWCX: GLNJX (14 years) vs SCWCX (25 years). GLNJX (2.56) is less costly to investors than SCWCX (1.78). GLNJX is a more actively managed with annual turnover of: 37.00 vs. SCWCX (32.00). GLNJX has a lower initial minimum investment than SCWCX: GLNJX (0) vs SCWCX (250). SCWCX annual gain was more profitable for investors over the last year : 9.54 vs. GLNJX (7.21). GLNJX return over 5 years is better than : 11.24 vs. SCWCX (10.23).
GLNJXSCWCXGLNJX / SCWCX
Total Expense Ratio2.101.78118%
Annual Report Gross Expense Ratio2.561.78144%
Fund Existence14 years25 years-
Gain YTD11.80012.04598%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets72.9M81.9B0%
Annual Yield % from dividends0.000.04-
Returns for 1 year7.219.5476%
Returns for 3 years39.1734.72113%
Returns for 5 years11.2410.23110%
Returns for 10 years55.2542.78129%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LDMIX16.95N/A
N/A
Lazard Developing Markets Equity Instl
SHSAX59.43N/A
N/A
BlackRock Health Sciences Opps Inv A
GRLLX20.90N/A
N/A
Goldman Sachs Enhanced U.S. Equity R
CBARX49.38N/A
N/A
Calvert Balanced R6
CMIUX16.16-0.03
-0.19%
Six Circles Mgd Eq Port Intl Uncons